• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝硬化患者血清硒和锌浓度与促纤维化及促血管生成细胞因子(FGF - 19和内皮糖蛋白)之间的关系。

Relationships between serum selenium and zinc concentrations versus profibrotic and proangiogenic cytokines (FGF-19 and endoglin) in patients with alcoholic liver cirrhosis.

作者信息

Prystupa Andrzej, Kiciński Paweł, Luchowska-Kocot Dorota, Błażewicz Anna, Kurys-Denis Ewa, Niedziałek Jarosław, Sak Jarosław, Panasiuk Lech

机构信息

Department of Internal Medicine, Medical University of Lublin, Lublin, Poland.

Department of Family Medicine, Medical University of Lublin, Lublin, Poland.

出版信息

Ann Agric Environ Med. 2017 Sep 21;24(3):544-548. doi: 10.26444/aaem/76937. Epub 2017 Sep 16.

DOI:10.26444/aaem/76937
PMID:28954507
Abstract

INTRODUCTION AND OBJECTIVE

Liver cirrhosis is a disease involving the liver parenchyma, which is characterised by fibrosis and impaired architectonics of the parenchyma with regenerative nodules. The aim of the study was to determine the relationship between stage of alcoholic liver cirrhosis, concentrations of selenium, zinc and profibrotic and proangiogenic cytokines (FGF-19, ENG).

MATERIAL AND METHODS

The study included 99 patients with alcoholic cirrhosis and 20 healthy subjects. Ion chromatography with UV/VIS detection was used for determination of zinc ions in the previously mineralized serum samples. The measurements of selenium were performed with the ContrAA700 high-resolution continuum source graphite tube atomic absorption spectrometer. ELISA was used to determine concentration of FGF-19 and ENG in serum samples.

RESULTS

Concentrations of zinc and selenium were significantly decreased in cirrhotic patients (p<0.001 for both). The highest concentration of FGF-19 was found in Child-Pugh stage C liver cirrhosis patients (806.9±650.3 pg/ml), and was significantly higher than observed in controls (p=0.005) and stage A patients (compensated cirrhosis) (p=0.02). The highest concentration of ENG was demonstrated in the control group (3.24±148 ng/ml) while the lowest in patients with decompensated cirrhosis (7.32±5.39 ng/ml and 7.92±4.18 ng/ml for stage B and C; p=0.03 and p=0.02, respectively). The use of the multiple-variable model demonstrated that the independent factors affecting the concentration of ENG were the concentration of bilirubin (p=0.02), INR (p=0.01) and duration of alcohol abuse (p=0.02). The independent determinants of FGF-19 concentrations were found to be the stage (severity) of liver cirrhosis (p=0.04) and INR (p=0.03).

CONCLUSIONS

Concentrations of zinc and selenium in serum of patients with alcoholic liver cirrhosis are not independently related to concentrations of FGF-19 and ENG.

摘要

引言与目的

肝硬化是一种累及肝实质的疾病,其特征为纤维化以及伴有再生结节的肝实质结构破坏。本研究的目的是确定酒精性肝硬化的阶段与硒、锌浓度以及促纤维化和促血管生成细胞因子(FGF - 19、ENG)之间的关系。

材料与方法

本研究纳入了99例酒精性肝硬化患者和20名健康受试者。采用配有紫外/可见检测的离子色谱法测定先前矿化血清样本中的锌离子。使用ContrAA700高分辨率连续光源石墨管原子吸收光谱仪进行硒的测量。采用酶联免疫吸附测定法(ELISA)测定血清样本中FGF - 19和ENG的浓度。

结果

肝硬化患者的锌和硒浓度显著降低(两者均p<0.001)。在Child - Pugh C期肝硬化患者中发现FGF - 19的浓度最高(806.9±650.3 pg/ml),且显著高于对照组(p = 0.005)和A期患者(代偿期肝硬化)(p = 0.02)。对照组中ENG的浓度最高(3.24±148 ng/ml),而失代偿期肝硬化患者中最低(B期和C期分别为7.32±5.39 ng/ml和7.92±4.18 ng/ml;p分别为0.03和0.02)。多变量模型分析表明,影响ENG浓度的独立因素为胆红素浓度(p = 0.02)、国际标准化比值(INR)(p = 0.01)和酒精滥用持续时间(p = 0.02)。发现FGF - 19浓度的独立决定因素为肝硬化的阶段(严重程度)(p = 0.04)和INR(p = 0.03)。

结论

酒精性肝硬化患者血清中的锌和硒浓度与FGF - 19和ENG的浓度无独立相关性。

相似文献

1
Relationships between serum selenium and zinc concentrations versus profibrotic and proangiogenic cytokines (FGF-19 and endoglin) in patients with alcoholic liver cirrhosis.酒精性肝硬化患者血清硒和锌浓度与促纤维化及促血管生成细胞因子(FGF - 19和内皮糖蛋白)之间的关系。
Ann Agric Environ Med. 2017 Sep 21;24(3):544-548. doi: 10.26444/aaem/76937. Epub 2017 Sep 16.
2
Association between Serum Selenium Concentrations and Levels of Proinflammatory and Profibrotic Cytokines-Interleukin-6 and Growth Differentiation Factor-15, in Patients with Alcoholic Liver Cirrhosis.酒精性肝硬化患者血清硒浓度与促炎和促纤维化细胞因子——白细胞介素-6及生长分化因子-15水平之间的关联
Int J Environ Res Public Health. 2017 Apr 21;14(4):437. doi: 10.3390/ijerph14040437.
3
PDGF-BB homodimer serum level - a good indicator of the severity of alcoholic liver cirrhosis.血小板衍生生长因子-BB同二聚体血清水平——酒精性肝硬化严重程度的良好指标。
Ann Agric Environ Med. 2020 Mar 17;27(1):80-85. doi: 10.26444/aaem/115997. Epub 2020 Jan 25.
4
Afamin and adropin in patients with alcohol-induced liver cirrhosis.酒精性肝硬化患者中的载脂蛋白A-F和内脂素
Ann Agric Environ Med. 2018 Sep 25;25(3):527-531. doi: 10.26444/aaem/92650. Epub 2018 Jul 25.
5
Study of trace elements in liver cirrhosis patients and their role in prognosis of disease.肝硬化患者微量元素的研究及其在疾病预后中的作用。
Biol Trace Elem Res. 2015 May;165(1):35-40. doi: 10.1007/s12011-015-0237-3. Epub 2015 Jan 24.
6
Decreased serum selenium in alcoholic cirrhosis.酒精性肝硬化患者血清硒水平降低。
N Engl J Med. 1980 Oct 16;303(16):944-5.
7
Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis.肝硬化患者血清锌、铜、锰和镁的浓度
Coll Antropol. 2006 Sep;30(3):523-8.
8
[Changes in blood Zn, Se, Cd, Pb during therapeutic abstinence from alcohol in 101 cases of alcoholism].
G Clin Med. 1989 Nov;70(11):653-4, 658-60.
9
Decreased serum selenium in alcoholics--a consequence of liver dysfunction.
Clin Chim Acta. 1983 Jun 15;130(3):291-6. doi: 10.1016/0009-8981(83)90303-0.
10
Serum Concentrations of Selected Heavy Metals in Patients with Alcoholic Liver Cirrhosis from the Lublin Region in Eastern Poland.波兰东部卢布林地区酒精性肝硬化患者血清中某些重金属的浓度
Int J Environ Res Public Health. 2016 Jun 13;13(6):582. doi: 10.3390/ijerph13060582.

引用本文的文献

1
The role and mechanism of selenium in the prevention and progression of hepatocellular carcinoma.硒在肝细胞癌预防和进展中的作用及机制。
Front Oncol. 2025 Mar 20;15:1557233. doi: 10.3389/fonc.2025.1557233. eCollection 2025.
2
Zinc supplementation to improve prognosis in patients with compensated advanced chronic liver disease: a multicenter, randomized, double-blind, placebo-controlled clinical trial.补锌改善代偿期晚期慢性肝病患者预后的多中心、随机、双盲、安慰剂对照临床试验。
Hepatol Commun. 2024 Oct 10;8(11). doi: 10.1097/HC9.0000000000000524. eCollection 2024 Nov 1.
3
The role of vitamin and microelement supplementation in the treatment of ethanol-induced liver disease.
维生素和微量元素补充剂在乙醇性肝病治疗中的作用
Prz Gastroenterol. 2022;17(4):253-256. doi: 10.5114/pg.2022.121820. Epub 2022 Dec 7.
4
Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的硒转录组网络
Front Nutr. 2021 Nov 17;8:744825. doi: 10.3389/fnut.2021.744825. eCollection 2021.
5
Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease.当前对慢性酒精性肝病中微量营养素代谢的理解。
World J Gastroenterol. 2020 Aug 21;26(31):4567-4578. doi: 10.3748/wjg.v26.i31.4567.
6
Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy.内皮糖蛋白(CD105)在肝细胞癌进展和抗血管生成治疗中的作用。
Int J Mol Sci. 2018 Dec 5;19(12):3887. doi: 10.3390/ijms19123887.